Iterative Health, a Massachusetts-based company with an international presence, has acquired the clinical research operations of Waco (Texas) Cardiology Associates along with cardiology research sites in Port Arthur and Beaumont, Texas — all three previously operated by NextStage Clinical Research, The Waco Tribune reported June 5.
The deal gives Iterative Health an established base of actively enrolled trial participants. Donald Cross, MD,, principal investigator at Waco Cardiology, said the practice currently has 200 to 250 people actively enrolled across trials covering heart failure, cardiovascular disease and weight-loss drugs, out of 350 total enrollments.
An Iterative Health spokesperson framed the Texas markets as a direct response to an access gap, noting that cardiovascular disease affects nearly half of all U.S. adults but trial access remains uneven across communities. Waco Cardiology Associates, founded in 1971, now operates eight offices in the region.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.